Global Pain Reliever Market Growth 2020-2025


Apr, 2020 | Report ID: 124926 | 162 | Pharmaceuticals and Healthcare

According to this study, over the next five years the Pain Reliever market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pain Reliever business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Pain Reliever market by type, application, key manufacturers and key regions and countries.
This study considers the Pain Reliever value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Generic Opioids
Branded Opioids
NSAIDs
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Clinics
Drugstores

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Depomed
GSK
Bayer
Sanofi
Grunenthal
Endo
Eli Lilly
Merck
AstraZeneca
Yunnan Baiyao
Allergan
J&J
Purdue
Teva
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Pain Reliever consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Pain Reliever market by identifying its various subsegments.
Focuses on the key global Pain Reliever manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pain Reliever with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pain Reliever submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pain Reliever Consumption 2015-2025
2.1.2 Pain Reliever Consumption CAGR by Region
2.2 Pain Reliever Segment by Type
2.2.1 Generic Opioids
2.2.2 Branded Opioids
2.2.3 NSAIDs
2.2.4 Others
2.3 Pain Reliever Consumption by Type
2.3.1 Global Pain Reliever Consumption Market Share by Type (2015-2020)
2.3.2 Global Pain Reliever Revenue and Market Share by Type (2015-2020)
2.3.3 Global Pain Reliever Sale Price by Type (2015-2020)
2.4 Pain Reliever Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Drugstores
2.5 Pain Reliever Consumption by Application
2.5.1 Global Pain Reliever Consumption Market Share by Type (2015-2020)
2.5.2 Global Pain Reliever Value and Market Share by Type (2015-2020)
2.5.3 Global Pain Reliever Sale Price by Type (2015-2020)
3 Global Pain Reliever by Company
3.1 Global Pain Reliever Sales Market Share by Company
3.1.1 Global Pain Reliever Sales by Company (2018-2020)
3.1.2 Global Pain Reliever Sales Market Share by Company (2018-2020)
3.2 Global Pain Reliever Revenue Market Share by Company
3.2.1 Global Pain Reliever Revenue by Company (2018-2020)
3.2.2 Global Pain Reliever Revenue Market Share by Company (2018-2020)
3.3 Global Pain Reliever Sale Price by Company
3.4 Global Pain Reliever Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Pain Reliever Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Pain Reliever Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Pain Reliever by Regions
4.1 Pain Reliever by Regions
4.2 Americas Pain Reliever Consumption Growth
4.3 APAC Pain Reliever Consumption Growth
4.4 Europe Pain Reliever Consumption Growth
4.5 Middle East & Africa Pain Reliever Consumption Growth
5 Americas
5.1 Americas Pain Reliever Consumption by Countries
5.1.1 Americas Pain Reliever Consumption by Countries (2015-2020)
5.1.2 Americas Pain Reliever Value by Countries (2015-2020)
5.2 Americas Pain Reliever Consumption by Type
5.3 Americas Pain Reliever Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Pain Reliever Consumption by Regions
6.1.1 APAC Pain Reliever Consumption by Regions (2015-2020)
6.1.2 APAC Pain Reliever Value by Regions (2015-2020)
6.2 APAC Pain Reliever Consumption by Type
6.3 APAC Pain Reliever Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Pain Reliever by Countries
7.1.1 Europe Pain Reliever Consumption by Countries (2015-2020)
7.1.2 Europe Pain Reliever Value by Countries (2015-2020)
7.2 Europe Pain Reliever Consumption by Type
7.3 Europe Pain Reliever Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Pain Reliever by Countries
8.1.1 Middle East & Africa Pain Reliever Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Pain Reliever Value by Countries (2015-2020)
8.2 Middle East & Africa Pain Reliever Consumption by Type
8.3 Middle East & Africa Pain Reliever Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Pain Reliever Distributors
10.3 Pain Reliever Customer
11 Global Pain Reliever Market Forecast
11.1 Global Pain Reliever Consumption Forecast (2021-2025)
11.2 Global Pain Reliever Forecast by Regions
11.2.1 Global Pain Reliever Forecast by Regions (2021-2025)
11.2.2 Global Pain Reliever Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Pain Reliever Forecast by Type
11.8 Global Pain Reliever Forecast by Application
12 Key Players Analysis
12.1 Pfizer
12.1.1 Company Information
12.1.2 Pain Reliever Product Offered
12.1.3 Pfizer Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Pfizer Latest Developments
12.2 Depomed
12.2.1 Company Information
12.2.2 Pain Reliever Product Offered
12.2.3 Depomed Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Depomed Latest Developments
12.3 GSK
12.3.1 Company Information
12.3.2 Pain Reliever Product Offered
12.3.3 GSK Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 GSK Latest Developments
12.4 Bayer
12.4.1 Company Information
12.4.2 Pain Reliever Product Offered
12.4.3 Bayer Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Bayer Latest Developments
12.5 Sanofi
12.5.1 Company Information
12.5.2 Pain Reliever Product Offered
12.5.3 Sanofi Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Sanofi Latest Developments
12.6 Grunenthal
12.6.1 Company Information
12.6.2 Pain Reliever Product Offered
12.6.3 Grunenthal Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Grunenthal Latest Developments
12.7 Endo
12.7.1 Company Information
12.7.2 Pain Reliever Product Offered
12.7.3 Endo Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Endo Latest Developments
12.8 Eli Lilly
12.8.1 Company Information
12.8.2 Pain Reliever Product Offered
12.8.3 Eli Lilly Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Eli Lilly Latest Developments
12.9 Merck
12.9.1 Company Information
12.9.2 Pain Reliever Product Offered
12.9.3 Merck Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Merck Latest Developments
12.10 AstraZeneca
12.10.1 Company Information
12.10.2 Pain Reliever Product Offered
12.10.3 AstraZeneca Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 AstraZeneca Latest Developments
12.11 Yunnan Baiyao
12.11.1 Company Information
12.11.2 Pain Reliever Product Offered
12.11.3 Yunnan Baiyao Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Yunnan Baiyao Latest Developments
12.12 Allergan
12.12.1 Company Information
12.12.2 Pain Reliever Product Offered
12.12.3 Allergan Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Allergan Latest Developments
12.13 J&J
12.13.1 Company Information
12.13.2 Pain Reliever Product Offered
12.13.3 J&J Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 J&J Latest Developments
12.14 Purdue
12.14.1 Company Information
12.14.2 Pain Reliever Product Offered
12.14.3 Purdue Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Purdue Latest Developments
12.15 Teva
12.15.1 Company Information
12.15.2 Pain Reliever Product Offered
12.15.3 Teva Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Teva Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Pain Reliever Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Generic Opioids
Table 5. Major Players of Branded Opioids
Table 6. Major Players of NSAIDs
Table 7. Major Players of Others
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Pain Reliever Consumption Market Share by Type (2015-2020)
Table 10. Global Pain Reliever Revenue by Type (2015-2020) ($ million)
Table 11. Global Pain Reliever Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Pain Reliever Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Pain Reliever Consumption Market Share by Application (2015-2020)
Table 15. Global Pain Reliever Value by Application (2015-2020)
Table 16. Global Pain Reliever Value Market Share by Application (2015-2020)
Table 17. Global Pain Reliever Sale Price by Application (2015-2020)
Table 18. Global Pain Reliever Sales by Company (2017-2019) (K Units)
Table 19. Global Pain Reliever Sales Market Share by Company (2017-2019)
Table 20. Global Pain Reliever Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Pain Reliever Revenue Market Share by Company (2017-2019)
Table 22. Global Pain Reliever Sale Price by Company (2017-2019)
Table 23. Global Pain Reliever Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Pain Reliever Products Offered
Table 25. Pain Reliever Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Pain Reliever Consumption by Regions 2015-2020 (K Units)
Table 27. Global Pain Reliever Consumption Market Share by Regions 2015-2020
Table 28. Global Pain Reliever Value by Regions 2015-2020 ($ Millions)
Table 29. Global Pain Reliever Value Market Share by Regions 2015-2020
Table 30. Americas Pain Reliever Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Pain Reliever Consumption Market Share by Countries (2015-2020)
Table 32. Americas Pain Reliever Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Pain Reliever Value Market Share by Countries (2015-2020)
Table 34. Americas Pain Reliever Consumption by Type (2015-2020) (K Units)
Table 35. Americas Pain Reliever Consumption Market Share by Type (2015-2020)
Table 36. Americas Pain Reliever Consumption by Application (2015-2020) (K Units)
Table 37. Americas Pain Reliever Consumption Market Share by Application (2015-2020)
Table 38. APAC Pain Reliever Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Pain Reliever Consumption Market Share by Countries (2015-2020)
Table 40. APAC Pain Reliever Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Pain Reliever Value Market Share by Regions (2015-2020)
Table 42. APAC Pain Reliever Consumption by Type (2015-2020) (K Units)
Table 43. APAC Pain Reliever Consumption Market Share by Type (2015-2020)
Table 44. APAC Pain Reliever Consumption by Application (2015-2020) (K Units)
Table 45. APAC Pain Reliever Consumption Market Share by Application (2015-2020)
Table 46. Europe Pain Reliever Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Pain Reliever Consumption Market Share by Countries (2015-2020)
Table 48. Europe Pain Reliever Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Pain Reliever Value Market Share by Countries (2015-2020)
Table 50. Europe Pain Reliever Consumption by Type (2015-2020) (K Units)
Table 51. Europe Pain Reliever Consumption Market Share by Type (2015-2020)
Table 52. Europe Pain Reliever Consumption by Application (2015-2020) (K Units)
Table 53. Europe Pain Reliever Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Pain Reliever Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Pain Reliever Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Pain Reliever Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Pain Reliever Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Pain Reliever Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Pain Reliever Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Pain Reliever Consumption by Application (2015-2020) (K Units)
Table 61. Middle East & Africa Pain Reliever Consumption Market Share by Application (2015-2020)
Table 62. Pain Reliever Distributors List
Table 63. Pain Reliever Customer List
Table 64. Global Pain Reliever Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Pain Reliever Consumption Market Forecast by Regions
Table 66. Global Pain Reliever Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Pain Reliever Value Market Share Forecast by Regions
Table 68. Global Pain Reliever Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Pain Reliever Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Pain Reliever Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Pain Reliever Value Market Share Forecast by Type (2021-2025)
Table 72. Global Pain Reliever Consumption Forecast by Application (2021-2025) (K Units)
Table 73. Global Pain Reliever Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Pain Reliever Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Pain Reliever Value Market Share Forecast by Application (2021-2025)
Table 76. Pfizer Product Offered
Table 77. Pfizer Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 78. Pfizer Main Business
Table 79. Pfizer Latest Developments
Table 80. Pfizer Basic Information, Company Total Revenue (in $ million), Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 81. Depomed Product Offered
Table 82. Depomed Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 83. Depomed Main Business
Table 84. Depomed Latest Developments
Table 85. Depomed Basic Information, Company Total Revenue (in $ million), Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 86. GSK Product Offered
Table 87. GSK Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 88. GSK Main Business
Table 89. GSK Latest Developments
Table 90. GSK Basic Information, Company Total Revenue (in $ million), Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 91. Bayer Product Offered
Table 92. Bayer Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 93. Bayer Main Business
Table 94. Bayer Latest Developments
Table 95. Bayer Basic Information, Company Total Revenue (in $ million), Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 96. Sanofi Product Offered
Table 97. Sanofi Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 98. Sanofi Main Business
Table 99. Sanofi Latest Developments
Table 100. Sanofi Basic Information, Company Total Revenue (in $ million), Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 101. Grunenthal Product Offered
Table 102. Grunenthal Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 103. Grunenthal Main Business
Table 104. Grunenthal Latest Developments
Table 105. Grunenthal Basic Information, Company Total Revenue (in $ million), Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 106. Endo Product Offered
Table 107. Endo Basic Information, Company Total Revenue (in $ million), Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 108. Endo Main Business
Table 109. Endo Latest Developments
Table 110. Endo Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. Eli Lilly Product Offered
Table 112. Eli Lilly Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. Eli Lilly Main Business
Table 114. Eli Lilly Latest Developments
Table 115. Eli Lilly Basic Information, Company Total Revenue (in $ million), Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 116. Merck Product Offered
Table 117. Merck Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 118. Merck Main Business
Table 119. Merck Latest Developments
Table 120. Merck Basic Information, Company Total Revenue (in $ million), Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 121. AstraZeneca Product Offered
Table 122. AstraZeneca Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 123. AstraZeneca Main Business
Table 124. AstraZeneca Latest Developments
Table 125. AstraZeneca Basic Information, Company Total Revenue (in $ million), Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 126. Yunnan Baiyao Product Offered
Table 127. Yunnan Baiyao Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 128. Yunnan Baiyao Main Business
Table 129. Yunnan Baiyao Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Yunnan Baiyao Latest Developments
Table 131. Allergan Product Offered
Table 132. Allergan Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 133. Allergan Main Business
Table 134. Allergan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. Allergan Latest Developments
Table 136. J&J Product Offered
Table 137. J&J Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 138. J&J Main Business
Table 139. J&J Latest Developments
Table 140. J&J Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 141. Purdue Product Offered
Table 142. Purdue Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 143. Purdue Main Business
Table 144. Purdue Latest Developments
Table 145. Purdue Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 146. Teva Product Offered
Table 147. Teva Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 148. Teva Main Business
Table 149. Teva Latest Developments
Table 150. Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Pain Reliever
Figure 2. Pain Reliever Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Pain Reliever Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Pain Reliever Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Generic Opioids
Figure 7. Product Picture of Branded Opioids
Figure 8. Product Picture of NSAIDs
Figure 9. Product Picture of Others
Figure 10. Global Pain Reliever Consumption Market Share by Type (2015-2020)
Figure 11. Global Pain Reliever Value Market Share by Type (2015-2020)
Figure 12. Pain Reliever Consumed in Hospitals
Figure 13. Global Pain Reliever Market: Hospitals (2015-2020) (K Units)
Figure 14. Global Pain Reliever Market: Hospitals (2015-2020) ($ Millions)
Figure 15. Pain Reliever Consumed in Clinics
Figure 16. Global Pain Reliever Market: Clinics (2015-2020) (K Units)
Figure 17. Global Pain Reliever Market: Clinics (2015-2020) ($ Millions)
Figure 18. Pain Reliever Consumed in Drugstores
Figure 19. Global Pain Reliever Market: Drugstores (2015-2020) (K Units)
Figure 20. Global Pain Reliever Market: Drugstores (2015-2020) ($ Millions)
Figure 21. Global Pain Reliever Consumption Market Share by Application (2015-2020)
Figure 22. Global Pain Reliever Value Market Share by Application (2015-2020)
Figure 23. Global Pain Reliever Sales Market Share by Company in 2017
Figure 24. Global Pain Reliever Sales Market Share by Company in 2019
Figure 25. Global Pain Reliever Revenue Market Share by Company in 2017
Figure 26. Global Pain Reliever Revenue Market Share by Company in 2019
Figure 27. Global Pain Reliever Sale Price by Company in 2019
Figure 28. Global Pain Reliever Consumption Market Share by Regions 2015-2020
Figure 29. Global Pain Reliever Value Market Share by Regions 2015-2020
Figure 30. Americas Pain Reliever Consumption 2015-2020 (K Units)
Figure 31. Americas Pain Reliever Value 2015-2020 ($ Millions)
Figure 32. APAC Pain Reliever Consumption 2015-2020 (K Units)
Figure 33. APAC Pain Reliever Value 2015-2020 ($ Millions)
Figure 34. Europe Pain Reliever Consumption 2015-2020 (K Units)
Figure 35. Europe Pain Reliever Value 2015-2020 ($ Millions)
Figure 36. Middle East & Africa Pain Reliever Consumption 2015-2020 (K Units)
Figure 37. Middle East & Africa Pain Reliever Value 2015-2020 ($ Millions)
Figure 38. Americas Pain Reliever Consumption Market Share by Countries in 2019
Figure 39. Americas Pain Reliever Value Market Share by Countries in 2019
Figure 40. Americas Pain Reliever Consumption Market Share by Type in 2019
Figure 41. Americas Pain Reliever Consumption Market Share by Application in 2019
Figure 42. United States Pain Reliever Consumption Growth 2015-2020 (K Units)
Figure 43. United States Pain Reliever Value Growth 2015-2020 ($ Millions)
Figure 44. Canada Pain Reliever Consumption Growth 2015-2020 (K Units)
Figure 45. Canada Pain Reliever Value Growth 2015-2020 ($ Millions)
Figure 46. Mexico Pain Reliever Consumption Growth 2015-2020 (K Units)
Figure 47. Mexico Pain Reliever Value Growth 2015-2020 ($ Millions)
Figure 48. APAC Pain Reliever Consumption Market Share by Countries in 2019
Figure 49. APAC Pain Reliever Value Market Share by Regions in 2019
Figure 50. APAC Pain Reliever Consumption Market Share by Type in 2019
Figure 51. APAC Pain Reliever Consumption Market Share by Application in 2019
Figure 52. China Pain Reliever Consumption Growth 2015-2020 (K Units)
Figure 53. China Pain Reliever Value Growth 2015-2020 ($ Millions)
Figure 54. Japan Pain Reliever Consumption Growth 2015-2020 (K Units)
Figure 55. Japan Pain Reliever Value Growth 2015-2020 ($ Millions)
Figure 56. Korea Pain Reliever Consumption Growth 2015-2020 (K Units)
Figure 57. Korea Pain Reliever Value Growth 2015-2020 ($ Millions)
Figure 58. Southeast Asia Pain Reliever Consumption Growth 2015-2020 (K Units)
Figure 59. Southeast Asia Pain Reliever Value Growth 2015-2020 ($ Millions)
Figure 60. India Pain Reliever Consumption Growth 2015-2020 (K Units)
Figure 61. India Pain Reliever Value Growth 2015-2020 ($ Millions)
Figure 62. Australia Pain Reliever Consumption Growth 2015-2020 (K Units)
Figure 63. Australia Pain Reliever Value Growth 2015-2020 ($ Millions)
Figure 64. Europe Pain Reliever Consumption Market Share by Countries in 2019
Figure 65. Europe Pain Reliever Value Market Share by Countries in 2019
Figure 66. Europe Pain Reliever Consumption Market Share by Type in 2019
Figure 67. Europe Pain Reliever Consumption Market Share by Application in 2019
Figure 68. Germany Pain Reliever Consumption Growth 2015-2020 (K Units)
Figure 69. Germany Pain Reliever Value Growth 2015-2020 ($ Millions)
Figure 70. France Pain Reliever Consumption Growth 2015-2020 (K Units)
Figure 71. France Pain Reliever Value Growth 2015-2020 ($ Millions)
Figure 72. UK Pain Reliever Consumption Growth 2015-2020 (K Units)
Figure 73. UK Pain Reliever Value Growth 2015-2020 ($ Millions)
Figure 74. Italy Pain Reliever Consumption Growth 2015-2020 (K Units)
Figure 75. Italy Pain Reliever Value Growth 2015-2020 ($ Millions)
Figure 76. Russia Pain Reliever Consumption Growth 2015-2020 (K Units)
Figure 77. Russia Pain Reliever Value Growth 2015-2020 ($ Millions)
Figure 78. Middle East & Africa Pain Reliever Consumption Market Share by Countries in 2019
Figure 79. Middle East & Africa Pain Reliever Value Market Share by Countries in 2019
Figure 80. Middle East & Africa Pain Reliever Consumption Market Share by Type in 2019
Figure 81. Middle East & Africa Pain Reliever Consumption Market Share by Application in 2019
Figure 82. Egypt Pain Reliever Consumption Growth 2015-2020 (K Units)
Figure 83. Egypt Pain Reliever Value Growth 2015-2020 ($ Millions)
Figure 84. South Africa Pain Reliever Consumption Growth 2015-2020 (K Units)
Figure 85. South Africa Pain Reliever Value Growth 2015-2020 ($ Millions)
Figure 86. Israel Pain Reliever Consumption Growth 2015-2020 (K Units)
Figure 87. Israel Pain Reliever Value Growth 2015-2020 ($ Millions)
Figure 88. Turkey Pain Reliever Consumption Growth 2015-2020 (K Units)
Figure 89. Turkey Pain Reliever Value Growth 2015-2020 ($ Millions)
Figure 90. GCC Countries Pain Reliever Consumption Growth 2015-2020 (K Units)
Figure 91. GCC Countries Pain Reliever Value Growth 2015-2020 ($ Millions)
Figure 92. Global Pain Reliever Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 93. Global Pain Reliever Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 94. Americas Pain Reliever Consumption 2021-2025 (K Units)
Figure 95. Americas Pain Reliever Value 2021-2025 ($ Millions)
Figure 96. APAC Pain Reliever Consumption 2021-2025 (K Units)
Figure 97. APAC Pain Reliever Value 2021-2025 ($ Millions)
Figure 98. Europe Pain Reliever Consumption 2021-2025 (K Units)
Figure 99. Europe Pain Reliever Value 2021-2025 ($ Millions)
Figure 100. Middle East & Africa Pain Reliever Consumption 2021-2025 (K Units)
Figure 101. Middle East & Africa Pain Reliever Value 2021-2025 ($ Millions)
Figure 102. United States Pain Reliever Consumption 2021-2025 (K Units)
Figure 103. United States Pain Reliever Value 2021-2025 ($ Millions)
Figure 104. Canada Pain Reliever Consumption 2021-2025 (K Units)
Figure 105. Canada Pain Reliever Value 2021-2025 ($ Millions)
Figure 106. Mexico Pain Reliever Consumption 2021-2025 (K Units)
Figure 107. Mexico Pain Reliever Value 2021-2025 ($ Millions)
Figure 108. Brazil Pain Reliever Consumption 2021-2025 (K Units)
Figure 109. Brazil Pain Reliever Value 2021-2025 ($ Millions)
Figure 110. China Pain Reliever Consumption 2021-2025 (K Units)
Figure 111. China Pain Reliever Value 2021-2025 ($ Millions)
Figure 112. Japan Pain Reliever Consumption 2021-2025 (K Units)
Figure 113. Japan Pain Reliever Value 2021-2025 ($ Millions)
Figure 114. Korea Pain Reliever Consumption 2021-2025 (K Units)
Figure 115. Korea Pain Reliever Value 2021-2025 ($ Millions)
Figure 116. Southeast Asia Pain Reliever Consumption 2021-2025 (K Units)
Figure 117. Southeast Asia Pain Reliever Value 2021-2025 ($ Millions)
Figure 118. India Pain Reliever Consumption 2021-2025 (K Units)
Figure 119. India Pain Reliever Value 2021-2025 ($ Millions)
Figure 120. Australia Pain Reliever Consumption 2021-2025 (K Units)
Figure 121. Australia Pain Reliever Value 2021-2025 ($ Millions)
Figure 122. Germany Pain Reliever Consumption 2021-2025 (K Units)
Figure 123. Germany Pain Reliever Value 2021-2025 ($ Millions)
Figure 124. France Pain Reliever Consumption 2021-2025 (K Units)
Figure 125. France Pain Reliever Value 2021-2025 ($ Millions)
Figure 126. UK Pain Reliever Consumption 2021-2025 (K Units)
Figure 127. UK Pain Reliever Value 2021-2025 ($ Millions)
Figure 128. Italy Pain Reliever Consumption 2021-2025 (K Units)
Figure 129. Italy Pain Reliever Value 2021-2025 ($ Millions)
Figure 130. Russia Pain Reliever Consumption 2021-2025 (K Units)
Figure 131. Russia Pain Reliever Value 2021-2025 ($ Millions)
Figure 132. Spain Pain Reliever Consumption 2021-2025 (K Units)
Figure 133. Spain Pain Reliever Value 2021-2025 ($ Millions)
Figure 134. Egypt Pain Reliever Consumption 2021-2025 (K Units)
Figure 135. Egypt Pain Reliever Value 2021-2025 ($ Millions)
Figure 136. South Africa Pain Reliever Consumption 2021-2025 (K Units)
Figure 137. South Africa Pain Reliever Value 2021-2025 ($ Millions)
Figure 138. Israel Pain Reliever Consumption 2021-2025 (K Units)
Figure 139. Israel Pain Reliever Value 2021-2025 ($ Millions)
Figure 140. Turkey Pain Reliever Consumption 2021-2025 (K Units)
Figure 141. Turkey Pain Reliever Value 2021-2025 ($ Millions)
Figure 142. GCC Countries Pain Reliever Consumption 2021-2025 (K Units)
Figure 143. GCC Countries Pain Reliever Value 2021-2025 ($ Millions)
Figure 144. Pfizer Pain Reliever Market Share (2018-2020)
Figure 145. Depomed Pain Reliever Market Share (2018-2020)
Figure 146. GSK Pain Reliever Market Share (2018-2020)
Figure 147. Bayer Pain Reliever Market Share (2018-2020)
Figure 148. Sanofi Pain Reliever Market Share (2018-2020)
Figure 149. Grunenthal Pain Reliever Market Share (2018-2020)
Figure 150. Endo Pain Reliever Market Share (2018-2020)
Figure 151. Eli Lilly Pain Reliever Market Share (2018-2020)
Figure 152. Merck Pain Reliever Market Share (2018-2020)
Figure 153. AstraZeneca Pain Reliever Market Share (2018-2020)
Figure 154. Yunnan Baiyao Pain Reliever Market Share (2018-2020)
Figure 155. Allergan Pain Reliever Market Share (2018-2020)
Figure 156. J&J Pain Reliever Market Share (2018-2020)
Figure 157. Purdue Pain Reliever Market Share (2018-2020)
Figure 158. Teva Pain Reliever Market Share (2018-2020)
Sample Request is not available